NASH is a liver disease with inflammation and damage from fat buildup. If you have NASH, consider participating in our study to help find new treatments.
Criteria & Qualifications:Â
• Must be 18 years or older.
• Diagnosed with Ulcerative Colitis.
• Is willing to provide medical records.
Compensation:
Contact us for more information
| Patient Population | |
|---|---|
| Study Status | Active |
Ulcerative Colitis is a type of IBD that causes inflammation, sores, and abdominal pain. This clinical trial is being conducted to evaluate the safety and efficacy of an investigational Alfa Induction Therapy in people with Ulcerative Colitis.
Criteria & Qualifications:
• Is at least 16 years of age or older.
• Is willing to provide medical records.
Compensation:
Contact us for more information
Nonalcoholic fatty liver disease (NAFLD) is a condition where fat accumulates in the liver. NASH, the more severe form, causes swelling and damage to the liver. Currently, there is no existing treatment for NASH.
Criteria & Qualifications:Â
• Is at least 18 years of age or older.
• Inflammation and liver damage, also known as Nonalcoholic steatohepatitis (NASH).
• Must be weight stable for 6 months.
Compensation: Up to $3,000.
Coming Soon!
This study investigates the progression of Chronic Heart Failure and tests new treatments aimed at improving heart function and quality of life in patients experiencing heart failure symptoms.
Criteria & Qualifications:
• More than 18 years old.
• Willing to participate in the study.
• Currently experiencing symptoms of heart failure.
Compensation:
Contact us for more information
Coming Soon!
Contribute to our research targeting Crohn's Disease within the scope of Inflammatory Bowel Disease. Your participation can lead to improved therapies and insights into this challenging condition
Criteria & Qualifications:
• Must be diagnosed with Crohn's Disease.
• Aged 18 years or older.
• Willing to participate in clinical research and follow study procedures.
Compensation:
Contact us for more information